Krajinovic M - Search Results

1

Multidrug resistance gene (MDR1) polymorphisms are associated with major molecular responses to standard-dose imatinib in chronic myeloid leukemia.

Dulucq S, Bouchet S, Turcq B, Lippert E, Etienne G, Reiffers J, Molimard M, Krajinovic M, Mahon FX. Dulucq S, et al. Among authors: krajinovic m. Blood. 2008 Sep 1;112(5):2024-7. doi: 10.1182/blood-2008-03-147744. Epub 2008 Jun 4. Blood. 2008. PMID: 18524988 Free article.

2

The pharmacogenetics of imanitib.

Dulucq S, Krajinovic M. Dulucq S, et al. Among authors: krajinovic m. Genome Med. 2010 Nov 30;2(11):85. doi: 10.1186/gm206. Genome Med. 2010. PMID: 21122163 Free PMC article.

3

Pharmacogenetic considerations for acute lymphoblastic leukemia therapies.

Dulucq S, Laverdière C, Sinnett D, Krajinovic M. Dulucq S, et al. Among authors: krajinovic m. Expert Opin Drug Metab Toxicol. 2014 May;10(5):699-719. doi: 10.1517/17425255.2014.893294. Epub 2014 Mar 27. Expert Opin Drug Metab Toxicol. 2014. PMID: 24673379 Review.

4

DNA variants in the dihydrofolate reductase gene and outcome in childhood ALL.

Dulucq S, St-Onge G, Gagné V, Ansari M, Sinnett D, Labuda D, Moghrabi A, Krajinovic M. Dulucq S, et al. Among authors: krajinovic m. Blood. 2008 Apr 1;111(7):3692-700. doi: 10.1182/blood-2007-09-110593. Epub 2007 Dec 20. Blood. 2008. PMID: 18096764 Free article.

5

Polymorphisms in multidrug resistance-associated protein gene 4 is associated with outcome in childhood acute lymphoblastic leukemia.

Ansari M, Sauty G, Labuda M, Gagné V, Laverdière C, Moghrabi A, Sinnett D, Krajinovic M. Ansari M, et al. Among authors: krajinovic m. Blood. 2009 Aug 13;114(7):1383-6. doi: 10.1182/blood-2008-11-191098. Epub 2009 Jun 10. Blood. 2009. PMID: 19515727 Free article.

6

Combining several polymorphisms of thymidylate synthase gene for pharmacogenetic analysis.

Krajinovic M, Costea I, Primeau M, Dulucq S, Moghrabi A. Krajinovic M, et al. Pharmacogenomics J. 2005;5(6):374-80. doi: 10.1038/sj.tpj.6500332. Pharmacogenomics J. 2005. PMID: 16130010

7

Polymorphism G80A in the reduced folate carrier gene and its relationship to methotrexate plasma levels and outcome of childhood acute lymphoblastic leukemia.

Laverdière C, Chiasson S, Costea I, Moghrabi A, Krajinovic M. Laverdière C, et al. Among authors: krajinovic m. Blood. 2002 Nov 15;100(10):3832-4. doi: 10.1182/blood.V100.10.3832. Blood. 2002. PMID: 12411325 Free article.

8

DNA variants in region for noncoding interfering transcript of dihydrofolate reductase gene and outcome in childhood acute lymphoblastic leukemia.

Al-Shakfa F, Dulucq S, Brukner I, Milacic I, Ansari M, Beaulieu P, Moghrabi A, Laverdière C, Sallan SE, Silverman LB, Neuberg D, Kutok JL, Sinnett D, Krajinovic M. Al-Shakfa F, et al. Among authors: krajinovic m. Clin Cancer Res. 2009 Nov 15;15(22):6931-8. doi: 10.1158/1078-0432.CCR-09-0641. Epub 2009 Oct 27. Clin Cancer Res. 2009. PMID: 19861437

9

ATF5 polymorphisms influence ATF function and response to treatment in children with childhood acute lymphoblastic leukemia.

Rousseau J, Gagné V, Labuda M, Beaubois C, Sinnett D, Laverdière C, Moghrabi A, Sallan SE, Silverman LB, Neuberg D, Kutok JL, Krajinovic M. Rousseau J, et al. Among authors: krajinovic m. Blood. 2011 Nov 24;118(22):5883-90. doi: 10.1182/blood-2011-05-355560. Epub 2011 Oct 4. Blood. 2011. PMID: 21972289 Free PMC article.

10

Role of MTHFR genetic polymorphisms in the susceptibility to childhood acute lymphoblastic leukemia.

Krajinovic M, Lamothe S, Labuda D, Lemieux-Blanchard E, Theoret Y, Moghrabi A, Sinnett D. Krajinovic M, et al. Blood. 2004 Jan 1;103(1):252-7. doi: 10.1182/blood-2003-06-1794. Epub 2003 Sep 4. Blood. 2004. PMID: 12958073 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

213 results

Search Page